New drug affords therapy for lethal sticky ldl cholesterol 2 min read Health New drug affords therapy for lethal sticky ldl cholesterol 1 month ago The primary human trial led by Monash College in Australia demonstrated the success of Muvalaplin. The primary oral drug ever developed to focus on Lp(a)... Read More